{
    "eid": "2-s2.0-85109406726",
    "title": "Development of a human antibody fragment directed against the alpha folate receptor as a promising molecule for targeted application",
    "cover-date": "2021-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "alpha folate receptor (FR\u03b1)",
        "Non-small-cell lung cancer (NSCLC)",
        "phage display",
        "targeted therapy",
        "variable domain of a heavy-chain (VH)"
    ],
    "authors": [
        "Nattihda Parakasikron",
        "Chatchai Chaotham",
        "Pithi Chanvorachote",
        "Chanida Vinayanuwattikun",
        "Visarut Buranasudja",
        "Pornchanok Taweecheep",
        "Kannika Khantasup"
    ],
    "citedby-count": 3,
    "ref-count": 62,
    "ref-list": [
        "IMGN853, a Folate Receptor-\u03b1 (FR\u03b1)-Targeting Antibody-Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FR\u03b1-Expressing Tumors",
        "Increased affinity leads to improved selective tumor delivery of single-chain Fv antibodies",
        "Mechanisms of FGFR-mediated carcinogenesis",
        "Overexpression of folate binding protein is associated with shortened progression-free survival in uterine adenocarcinomas",
        "Selection and identification of single domain antibody fragments from camel heavy-chain antibodies",
        "Phage display technology: clinical applications and recent innovations",
        "Molecular imaging of tumors with nanobodies and antibodies: Timing and dosage are crucial factors for improved in vivo detection",
        "Crystal structure of a human single domain antibody dimer formed through V(H)-V(H) non-covalent interactions",
        "Isolating recombinant antibodies against specific protein morphologies using atomic force microscopy and phage display technologies",
        "The structure, function, and clinical prospects of antibody fragments",
        "Production and characterization of a murine monoclonal antibody against human ferritin",
        "Phage display\u2013a powerful technique for immunotherapy: 1",
        "Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay",
        "Rationale for folate receptor alpha targeted therapy in \"high risk\" endometrial carcinomas",
        "Concepts in antibody phage display",
        "Single antibody domains as small recognition units: design and in vitro antigen selection of camelized, human VH domains with improved protein stability",
        "Advances in targeting the folate receptor in the treatment/imaging of cancers",
        "TGF-\u03b2 Sustains Tumor Progression through Biochemical and Mechanical Signal Transduction",
        "The antifolates: evolution, new agents in the clinic, and how targeting delivery via specific membrane transporters is driving the development of a next generation of folate analogs",
        "Construction of a semisynthetic human VH single-domain antibody library and selection of domain antibodies against \u03b1-crystalline of mycobacterium tuberculosis",
        "Properties, production, and applications of camelid single-domain antibody fragments",
        "Folate receptor overexpression is associated with poor outcome in breast cancer",
        "Human Epidermal Growth Factor Receptor 2 (HER2) in cancers: overexpression and therapeutic implications",
        "Expression status of folate receptor alpha is significantly correlated with prognosis in non-small-cell lung cancers",
        "Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer",
        "Folate receptor alpha as a tumor target in epithelial ovarian cancer",
        "Phase I study of 68Ga-HER2-nanobody for PET/CT assessment of HER2 expression in breast carcinoma",
        "Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I study",
        "Antagonists of TNF action: clinical experience and new developments",
        "Antibody-drug conjugates designed to eradicate tumors with homogeneous and heterogeneous expression of the target antigen",
        "Drug-conjugated antibodies for the treatment of cancer",
        "Selection of human antibody fragments by phage display",
        "Monoclonal antibody against G Glycoprotein increases respiratory syncytial virus clearance in vivo and prevents vaccine-enhanced diseases",
        "In vitro affinity maturation of a natural human antibody overcomes a barrier to in vivo affinity maturation",
        "Development of a Phage display panning strategy utilizing crude antigens: isolation of MERS-CoV nucleoprotein human antibodies",
        "Disulfide bond structures of IgG molecules: structural variations, chemical modifications and possible impacts to stability and biological function",
        "SHuffle, a novel Escherichia coli protein expression strain capable of correctly folding disulfide bonded proteins in its cytoplasm",
        "The antigen-binding characteristics of mAbs derived from in vivo priming of avian B cells",
        "A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer",
        "Production of a high-affinity monoclonal antibody reactive with folate receptors alpha and beta",
        "Characterization of human monoclonal antibodies directed against the pp65-kD matrix antigen of human cytomegalovirus",
        "Design, synthesis, and characterization of folate-targeted platinum-loaded theranostic nanoemulsions for therapy and imaging of ovarian cancer",
        "Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models",
        "Impaired Phagocytosis in Dendritic Cells From Pediatric Patients With Type 1 Diabetes Does Not Hamper Their Tolerogenic Potential",
        "Influence of affinity and antigen internalization on the uptake and penetration of Anti-HER2 antibodies in solid tumors",
        "Profile of farletuzumab and its potential in the treatment of solid tumors",
        "Assessment of folate receptor alpha and beta expression in selection of lung and pancreatic cancer patients for receptor targeted therapies",
        "Assessment of folate receptor-\u03b2 expression in human neoplastic tissues",
        "Improving the efficacy and safety of engineered T cell therapy for cancer",
        "Cancer statistics, 2017",
        "Chemistry of Renieramycins. 15. Synthesis of 22-O-Ester Derivatives of Jorunnamycin A and Their Cytotoxicity against Non-Small-Cell Lung Cancer Cells",
        "High-affinity internalizing human scFv-Fc antibody for targeting FGFR1-overexpressing lung cancer",
        "Principles in the design of ligand-targeted cancer therapeutics and imaging agents",
        "MUC1 Story: Great Expectations, Disappointments and the Renaissance",
        "Specific organ metastases and survival in metastatic non-small-cell lung cancer",
        "Diverse human V(H) antibody fragments with bio-therapeutic properties from the Crescendo Mouse",
        "Cancer treatment using peptides: current therapies and future prospects",
        "Expression of folate binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancer",
        "Structures of human folate receptors reveal biological trafficking states and diversity in folate and antifolate recognition",
        "Applications and strategies in nanodiagnosis and nanotherapy in lung cancer",
        "Antibody or Antibody Fragments: Implications for Molecular Imaging and Targeted Therapy of Solid Tumors",
        "The emerging treatment landscape of targeted therapy in non-small-cell lung cancer"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "CUAASC",
        "Chulalongkorn Academic Advancement",
        "Department of Biochemistry and Microbiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University",
        "Second Century Fund",
        "Chulalongkorn university"
    ]
}